McPsychedelics: The Rise of Psychedelic Individualism
The psychedelic renaissance isn’t new—it’s been quietly gaining momentum since the early 1990s. However, what we’re witnessing now is a peculiar new phase, one that’s both promising and concerning. This latest chapter, which I call McPsychedelics, takes the profound potential of these substances and packages them into convenient, profit-driven experiences that contribute to the very economic systems creating the need for healing.
Much like McMindfulness, which diluted the transformative power of mindfulness into something marketable and superficial, McPsychedelics represents a commercialization of sacred medicines. Rather than fostering genuine spiritual growth or collective healing, psychedelics are increasingly used for ego-serving purposes. This phase of the psychedelic renaissance reflects a societal context steeped in materialism and individualism, overshadowing teachings of interconnection and self-transcendence.
Yet, beneath the commercialization lies the enduring potential for psychedelics to reconnect us to nature, community, and the sacred. This tension between exploitation and deeper purpose defines the current moment.
A McPsychedelics advertisement. Become an “awakened leader” today!
What is McPsychedelics?
McPsychedelics manifests in various ways. One prominent example is the rise of social media influencers and self-styled “shamans” marketing themselves as spiritual guides despite minimal personal experience or professional training rooted in lineage or institutional authority. Social-media platforms are flooded with promotions for plant medicine retreats and microdosing regimens from influencers who often emphasize optimization, productivity, and instant liberation—for a fee—catering more to ego enhancement than authentic healing and spiritual growth.
Another example is the proliferation of luxury wellness retreats targeting affluent individuals. These retreats promise personal transformation and success rather than communal healing or deeper connections to nature, spirit or community. These experiences, designed to cater to wealthy clients, risk reducing psychedelics to quick fixes rather than tools for meaningful change.
Most troubling is the corporate exploitation of traditional psychedelic practices. Companies like Compass Pathways have sought to patent basic therapeutic elements like sound systems and comfortable furniture, raising ethical questions about access and equity. This commodification risks prioritizing profits over the wellbeing of those who could benefit most from these therapies and healing modalities.
Unethical practices in psychedelic therapy further illustrate McPsychedelics' shadow side. Some therapists exploit their clients, justifying inappropriate behavior as part of the “healing process.” Such abuses harm individuals and undermine the integrity of psychedelic therapy as a whole. Additionally, psychedelics are sometimes misused to reinforce extreme ideologies, betraying their traditional purpose of fostering empathy and self-awareness.
Tradition & the Sacred
Before the rise of McPsychedelics, psychedelics like ayahuasca and psilocybin were integral to spiritual and healing practices worldwide. These substances were used ceremonially, guided by experienced shamans who understood their potential for communal and spiritual healing.
In the Amazon, the Shipibo people conduct ayahuasca ceremonies to heal both individuals and communities. Similarly, the Mazatec people of Mexico use psilocybin mushrooms in ceremonies designed to foster connection to nature and the spirit realm. These traditions emphasize reverence for the plants and fungi, collective healing, and spiritual guidance—values often lost in modern commercialized contexts.
As psychedelics are co-opted by corporate and individualistic interests, their sacred and communal aspects risk being overshadowed. Remembering their roots in Indigenous practices is crucial to preserving their potential for deeper healing and connection.
The Shadow Side of the Psychedelic Renaissance
The psychedelic renaissance’s darker side stems from its entanglement with individualism, corporatization, and exploitation. What began as a movement for awakening and healing is increasingly shaped by profit-driven interests.
The debate over legalization highlights these tensions. While psychedelics offer transformative potential for mental health treatment, corporations are vying for control, often pushing models that prioritize profit over accessibility. Patenting basic therapeutic practices risks pricing out the communities who could benefit most from psychedelic healing practices and therapy.
The rise of fraudulent guides and unethical therapists also exacerbates these issues. Self-proclaimed shamans exploit vulnerable individuals, lacking the training needed for safe facilitation. In extreme cases, therapists abuse their authority, causing harm and casting doubt on the legitimacy of psychedelics as medicine and legitimate adjuncts to therapy and spiritual discovery.
These trends reflect a deeper clash between the transformative essence of psychedelics and a culture obsessed with power and profit. Without critical awareness, psychedelics risk becoming commodified tools that reinforce, rather than challenge, societal dysfunction.
Set & Setting of the Modern World
Set and setting—the internal mindset and external environment of a psychedelic experience—are fundamental to healing. Yet, today’s broader societal set and setting—defined by materialism and individualism—shapes how psychedelics are used.
In this context, psychedelics are marketed as quick fixes for success and self-optimization. Historically used to transcend the ego, they are now employed to serve ego-driven pursuits. This undermines their potential to challenge societal values and foster deeper healing.
Corporations capitalize on this trend, offering sanitized, commodified versions of psychedelic experiences. These products promise easy results, bypassing the challenging inner work genuine healing requires. This reflects a broader cultural preference for convenience and results over transformation and process, reducing psychedelics to yet another consumer product.
As psychedelics enter the mainstream, they risk being commodified into “psychedelic Happy Meals”—mass-market products promising happiness without the hard work of healing. Pharmaceutical companies are developing convenient, patented psychedelic pills that strip away the transformative essence of these substances. This “one-size-fits-all” approach neglects the spiritual and communal dimensions central to traditional psychedelic use.
By reducing psychedelics to quick fixes, we lose their potential for deep emotional and spiritual breakthroughs. The sanitized, corporate-friendly version of psychedelics fails to honor their roots as allies for confronting pain and teachers in fostering insight, interconnectedness and self-transcendence.
Psychedelics & the Medical Establishment
The medicalization of psychedelics risks reducing their profound potential to sterile, symptom-focused treatments. Pharmaceutical companies are investing heavily in psychedelic therapies, aiming to position them as the next big breakthrough in mental health. However, this reductionist approach often neglects the broader societal and spiritual dimensions of healing.
Indigenous traditions emphasize communal and spiritual healing, addressing the whole person. In contrast, medicalized psychedelics risk being treated as quick fixes, stripped of their deeper layers of meaning. This shift reflects a broader trend in mental health treatment, where systemic issues are ignored in favor of managing symptoms.
While medicalization may increase access and legitimacy, it is essential to ensure that psychedelics are used in ways that honor their transformative potential. Reducing them to mere pharmaceuticals risks losing their capacity to foster spiritual growth, ecological awareness and planetary health.
A Trojan Horse for Wisdom?
Despite its flaws, McPsychedelics may serve as a gateway to deeper healing and understanding. For many, initial exposure to commercialized psychedelics could spark a journey of spiritual and ecological rediscovery. Psychedelics have the power to reconnect individuals with the sacred, offering insights into their interconnectedness with nature and the sacredness of life.
McPsychedelics is not the end of the story. As more people encounter psychedelics, there is hope for a shift toward deeper, more responsible use. Psychedelics hold the potential to heal not just individuals but also communities and ecosystems. To realize this potential, we must approach them with respect and intention, resisting the forces of commodification.
This means seeking out experiences rooted in authenticity and connection, avoiding superficial promises of quick fixes. True healing requires confronting discomfort and embracing the challenging journey toward transformation. By honoring the sacred potential of psychedelics, we can reclaim them as tools for collective healing and reconnection with the Earth.
If you enjoyed reading this article, please consider supporting us by following us on Instagram. If you need guidance or support with your psychedelic use, book a support call with a member of our team.
References
Carhart-Harris, R. L., & Friston, K. J. (2019). REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics. Pharmacological Reviews, 71(3), 316–344. https://doi.org/10.1124/pr.118.017160
Fadiman, J., & Korb, S. (2020). Microdosing: The breakthrough solution for depression, anxiety, PTSD, and chronic pain. Simon & Schuster.
Grinspoon, L., & Bakalar, J. B. (1997). Psychedelic drugs reconsidered. The Lindesmith Center.
Nichols, D. E. (2016). Psychedelics. Pharmacological Reviews, 68(2), 264–355. https://doi.org/10.1124/pr.115.011478
Williams, M. T., Reed, S., & George, D. (2020). Culture and psychedelic psychotherapy: Ethnic and racial themes from three Black women therapists. Journal of Psychedelic Studies, 4(2), 48–60. https://doi.org/10.1556/2054.2020.00137
Winkelman, M. J. (2017). The mechanisms of psychedelic visionary experiences: Hypotheses from evolutionary psychology. Frontiers in Neuroscience, 11, 539. https://doi.org/10.3389/fnins.2017.00539
